Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE (0.11%), DAX +0.17%, CAC40 (0.10%)

Apr 29 ,2026

  • Synopsis

    • European equity markets are set for a mixed to lower open amidst mixed Asian equities Wednesday. Semis weighing on Taiwan's benchmark following record-setting run. South Korea flat. Hong Kong leading China market gains. Japan closed for public holiday. S&P 500 futures inching higher afterhours.

    • UK weekly PMQs gets underway at 12noon BST, whilst committee topics include supercharging the EV transition at 9:15. There's an informal meeting of EU telecommunications ministers (through Thu). Germany's ministry of economic affairs and energy hosts National Maritime Conf (through Thu). Norway's minister for climate and environment Eriksen attends CICERO Center for International Climate Research Climate Day. Norwegian Farmers' Assns will present their demand for the 2026 agricultural negotiations.

    • In central banks, Bundesbank's Balz speech at 8:00CET at the Global Currency Forum, organised by the International Currency Association (Mon-Thu). BOE's Truran speech at 9:30BST at the 23rd conf on bulk annuities and Benjamin panellist at 11:45 at Moody's London credit frontiers Europe 'Regulation in focus'. ECB's Buch presentation at 16:30CET at the Danish Economic Society.

    • A slew of macro data on the agenda including Germany Apr preliminary CPI, Italy Apr business/consumer confidence, Spain Apr preliminary CPI, Eurozone Apr economic/service sentiment, Mar M3 money supply, Switzerland Apr expectations - ZEW, Norway Mar retail sales, Sweden Q1 preliminary GDP, Mar retail sales, Belgium Q1 preliminary GDP, Apr CPI, Mar PPI, Greece Mar unemployment rate, Ireland Q1 preliminary CPI, Apr preliminary HICP and Portugal Mar unemployment rate.

    • A busy morning for earnings with Q1 results out from Royal KPN (KPN.NA), Deutsche Bank (DBK.GR), UBS Group (UBSG.SW), Mercedes-Benz Group (MBG.GR), Wacker Chemie (WCH.GR), FUCHS (FPE3.GR), DWS Group (DWS.GR), Symrise (SY1.GR) and Straumann Holding (STMN.SW). From France, Airbus (AIR.FP), Teleperformance (TEP.FP), Worldline (WLN.FP), Aeroport de Paris (ADP.FP), Bic (BB.FP) and Amundi (AMUN.FP) are out with Q1 updates. In the Nordics, Swedbank (SWED.A.SS), Norsk Hydro (NHY.NO), Skandinaviska Enskilda Banken (SEB.A.SS), Volvo Car (VOLCAR.B.SS), Gjensidige Forsikring (GJF.NO), DSV (DSV.DC) and Kone (KNEBV.FH) are amongst companies reporting Q1 earnings. Elsewhere, Banco Santander (SAN.SM) and Prudential (PRU.LN) are out with Q1

  • Politics/Macro/World News

    • King Charles promotes US-UK unity in speech to Congress amid Iran tensions - Reuters

    • Trump tells aides to prepare for extended naval blockade in bid to pressure Iran on nuclear issue - media report

  • Top company news

    • Earnings/updates

      • Benelux:

        • KPN.NA (Royal KPN) -- reports Q1 net income €200M vs FactSet €209.2M [3 est, €194.8-223.7M]; on track to deliver FY26 outlook

        • MELE.BB (Melexis) -- reports Q1 EPS €0.57 vs FactSet €0.61 [5 est, €0.58-0.63]

        • ONTEX.BB (Ontex Group) -- reports Q1 adj EBITDA €38.6M vs FactSet €39.3M [2 est, €39.1-39.4M]; maintains its FY outlook

      • France:

        • AIR.FP (Airbus SE) -- reports Q1 adjusted EBIT €300M vs consensus €348M; 2026 guidance unchanged

        • TEP.FP (Teleperformance) -- reports Q1 revenue €2.43B vs FactSet €2.41B [2 est, €2.39-2.42B]

        • WLN.FP (Worldline) -- reports Q1 revenue €831M vs consensus €826.0M

        • ADP.FP (Aeroport de Paris) -- reports Q1 revenue €1.47B vs FactSet €1.55B [5 est, €1.54-1.56B]; reaffirms FY guidance

        • BB.FP (Bic) -- reports Q1 revenue €453M vs consensus €447M

        • AMUN.FP (Amundi) -- reports Q1 adjusted net income €349M vs consensus €318M

        • ATE.FP (Alten) -- reports Q1 revenue €1.05B vs FactSet €1.06B [2 est, €1.06-1.06B]; organic growth + 0.1%

        • SOP.FP (Sopra Steria Group) -- reports Q1 revenue €1.46B, +3.4% vs year-ago €1.42B

        • VETO.FP (Vetoquinol) -- reports Q1 revenue €125.0M, (4%) vs year-ago €130.6M

        • LSS.FP (Lectra) -- reports Q1 net income €0.5M vs FactSet €2.3M [1 est]; anticipates a significant rebound in equipment revenues in Q2 compared with Q1

        • CDA.FP (Compagnie des Alpes) -- reports preliminary Q2 revenue €593.7M vs FactSet €620.6M [1 est]

        • MRN.FP (Mersen) -- reports Q1 revenue €296.4M vs FactSet €292.0M [1 est]; organic growth of 3.1% y/y; confirms 2026 Guidance

        • PIG.FP (Haulotte Group) -- reports H1 revenue €121M, (8%) vs year-ago €131M

        • MTU.FP (Manitou BF) -- reports H1 revenue €648.0M, +8% vs year-ago €600.0M

        • ALTHX.FP (THX Pharma) -- reports FY net income (€3.0M) vs year-ago (€1.8M)

        • ALTA.FP (Altarea) -- reports Q1 revenue €381.4M, (12%) vs year-ago €435.3M

      • DACHs:

        • DBK.GR (Deutsche Bank) -- reports Q1 net income €2.17B vs consensus €1.77B; on track to deliver strong operating performance in 2026

        • UBSG.SW (UBS Group) -- reports Q1 EPS $0.94 vs consensus $0.72

        • MBG.GR (Mercedes-Benz Group) -- reports Q1 EPS €1.49 vs StreetAccount €1.30

        • WAF.GR (Siltronic) -- reports Q1 EPS (€1.92) vs FactSet (€1.78) [4 est, (€2.10)-(1.46)]

        • WCH.GR (Wacker Chemie) -- reports Q1 EPS €0.21 vs FactSet €0.11 [4 est, (€0.38)-0.65]; revenues and EBITDA in line with prelims; says guidance subject to high degree of uncertainty

        • ALSN.SW (ALSO Holding) -- reports Q1 adjusted EBITDA €89.0M, +46% y/y

        • FPE3.GR (FUCHS) -- reports Q1 EPS €0.68 vs FactSet €0.60 [4 est, €0.56-0.62]; confirms FY26 EBIT outlook, adjusts FY26 sales and cash flow expectations

        • HLE.GR (FORVIA HELLA) -- reports Q1 EPS €0.29 vs year-ago €0.19; company outlook for FY26 confirmed

        • DWS.GR (DWS Group) -- reports Q1 net income €264M vs consensus €215M; outlook unchanged

        • G24.GR (Scout24) -- reports Q1 EPS €0.95 ex-items vs FactSet €0.92 [1 est]; FY guidance confirmed

        • SY1.GR (Symrise) -- reports Q1 revenue €1.25B vs consensus €1.23B; organic sales decline of (0.4%); reaffirms FY 2026 outlook

        • STMN.SW (Straumann Holding) -- reports Q1 revenue CHF672.5M vs consensus CHF668.9M; FY26 outlook confirmed

        • HPHA.GR (Heidelberg Pharma) -- reports Q1 EPS (€0.09) vs year-ago (€0.13); confirms FY26 forecast; the group is financed until mid-2027

        • SDZ.SW (Sandoz Group) -- reports Q1 revenue $2.76B vs FactSet $2.74B [3 est, $2.66-2.80B]

        • 4FZ.GR (Orbia Advance Corp SAB de CV) -- Orbia Advance Corp SAB de CV reports Q1 net majority income ($38M) vs year-ago ($54M)

        • HYQ.GR (Hypoport) -- reports preliminary Q1 EBIT €12.1M vs year-ago €8.6M

        • NA9.GR (Nagarro) -- reports FY net income €39.5M vs FactSet €46.8M [3 est, €40-53M]

        • HBAN.SW (Helvetia Baloise Holding) -- publishes financial condition report for the 2025 financial year

      • Nordics:

        • SWED.A.SS (Swedbank) -- reports Q1 EPS SEK6.50 vs consensus SEK6.47

        • NHY.NO (Norsk Hydro) -- reports Q1 adj EPS NOK2.07 vs consensus NOK1.37

        • SEB.A.SS (Skandinaviska Enskilda Banken) -- reports Q1 EPS SEK3.79 vs consensus SEK3.60

        • VOLCAR.B.SS (Volvo Car) -- reports Q1 EPS SEK0.54 vs FactSet SEK0.25 [5 est, SEK0.10-0.44]; Q2 profitability will be affected by continued headwinds and the EX60 production start and ramp-up

        • GJF.NO (Gjensidige Forsikring) -- reports Q1 net income from cont ops NOK1.55B vs consensus NOK1.44B

        • DSV.DC (DSV) -- reports Q1 net income DKK1.64B vs consensus DKK1.70B; reiterates FY26 guidance for EBIT before special items

        • KNEBV.FH (Kone) -- reports Q1 EPS €0.41 vs consensus €0.43; specifies FY26 outlook

        • MGN.NO (Magnora) -- reports Q1 net income (NOK44.7M) vs year-ago NOK38.6M

        • MTG.B.SS (Modern Times Group MTG) -- reports Q1 net income SEK138M vs FactSet SEK130.1M [7 est, SEK65-190M]

        • STB.NO (Storebrand) -- reports Q1 cash EPS NOK2.10 vs consensus NOK2.35

        • NCC.B.SS (NCC) -- reports Q1 EPS (SEK1.90) vs consensus (SEK1.85)

        • KESKOB.FH (Kesko) -- reports Q1 comparable EPS €0.14 vs FactSet €0.14 [7 est, €0.13-0.14]; reiterates expectations for FY26 comparable operating profit of €650-750M vs FactSet 701M

        • RILBA.DC (Ringkjøbing Landbobank) -- reports Q1 EPS DKK24.30 vs FactSet DKK23.54 [3 est, DKK23.31-23.80]; confirms FY outlook

        • EGTX.SS (Egetis Therapeutics) -- reports Q1 EPS (SEK0.20) vs year-ago (SEK0.20)

        • STOR.B.SS (Storskogen Group) -- reports Q1 EPS SEK0.13 ex-items vs FactSet SEK0.16 [2 est, SEK0.15-0.17]

        • ICEAIR.IR (Icelandair Group) -- reports Q1 net income ($45.3M) vs year-ago ($44.1M)

      • Southern Europe:

        • SAN.SM (Banco Santander) -- reports Q1 underlying net income €3.56B vs consensus €3.47B; on track to meet FY26 targets

        • PUIG.SM (Puig Brands) -- reports Q1 revenue €1.22B vs StreetAccount €1.21B; LFL +4.7% vs StreetAccount +3.9%; reconfirms guidance for 2026

      • UK:

        • PRU.LN (Prudential) -- reports Q1 APE sales $1.82B vs StreetAccount $1.88B

      • Also reporting today

        • Sopra Steria Group (SOP.FP)

    • M&A

      • KNEBV.FH (KONE) -- and TKE to combine; KONE to acquire all assets of TK Elevator GmbH for a cash consideration of €5B and max share consideration of 270M newly issued KONE B shares

      • BF.B (Brown-Forman) -- and Pernod-Ricard (RI.FP) terminate merger talks -- Bloomberg

      • KNEBV.FH (Kone) -- nearing €29B cash-and-stock deal to acquire TK Elevator - Bloomberg

      • NEXI.IM (Nexi SpA) -- CVC weighs fresh €9B bid for Nexi; deal would carve out digital banking solutions arm -- FT, citing sources

      • BF.B (Brown-Forman) -- and Pernod Ricard Terminate Discussions Regarding Potential Combination

      • ENI.IM (Eni) -- exploring sale of cracking operations in Brindisi - Reuters, citing source familiar with the matter

      • ORA.FP (Orange) -- announces the signing of a €1.3B financing agreement with CaixaBank and BNP Paribas, intended for the acquisition of Scorefit

      • BNP.FP (BNP Paribas) -- and Ageas finalize agreement on selling its 25% stake in AG Insurance to Ageas for ~€1.9B

      • WLN.FP (Worldline) -- ANZ Group to acquire Worldline S.A's 51% share in ANZ Worldline for an enterprise value of A$89M (51% basis)

      • UPM.FH (UPM-Kymmene) -- European Commission to open in-depth investigation into UPM-Sappi graphic paper JV -- Reuters, citing statement

      • EMGS.NO (Electromagnetic Geoservices) -- completes asset sale transaction with P-2 Riggs Capital, Inc.

    • Healthcare

      • AZN.LN (AstraZeneca) -- FDA releases briefing materials ahead of Thursday adcom (earlier, timing uncertain)

      • PTCT (PTC Therapeutics) -- reports topline results from month 24 interim analysis of PIVOT-HD extension study of votoplam; Conf call at 16:30ET

      • GLPG.NA (Galapagos) -- Galapagos' Shareholders Adopt All Resolutions at the shareholders meeting; approve name change to Lakefront Biotherapeutics

      • 500124.IN (Dr. Reddy's Laboratories) -- Health Canada approves first generic of Ozempic - Bloomberg

      • 500124.IN (Dr. Reddy's Laboratories) -- confirms receipt of marketing authorization for generic semaglutide injection in Canada

      • HIK.LN (Hikma Pharmaceuticals) -- issues press release on settlement agreement for VYNDAMAX

      • ONCIN.NO (Oncoinvent) -- to hold live webcast presenting a corporate update today at 08:00 CET

    • Other

      • VOW3.GR (Volkswagen) -- to no longer produce VW Group products in Osnabrück from 2027; in intensive discussions with defense companies -- Bild, citing CEO interview

      • AIR.FP (Airbus SE) -- reported softer Q1 results, reaffirmed FY guidance:

      • GLEN.LN (Glencore) -- releases sustainability report

      • ENI.IM (Eni) -- provides update on activities in Venezuela after CEO meeting with Acting President

      • ZURN.SW (Zurich Insurance Group) -- publishes Financial Condition Report 2025

      • CA.FP (Carrefour) -- Transcript Intelligence: Carrefour at Deutsche Bank ADR Virtual Investor Conference

      • G24.GR (Scout24) -- SE resolves to launch a second tranche of its share buy-back programme of up to €250M in 2026 and to shorten the buy-back period of the ongoing tranche

      • FRVIA.FP (Forvia) -- announces implemenation of share buyback program approved by the shareholders' meeting held on 28-May-25

      • FGR.FP (Eiffage) -- announced as part of consortium in new concession contract for Parisian heat network

      • EQT.SS (EQT AB) -- considering IPO for New Zealand retirement living business Metlifecare - The Australian

      • RDC.GR (Redcare Pharmacy) -- announces Dirk Brüse to step down as CCO

      • ELI.BB (Elia Group SA/NV) -- Elia Group announces placement of €900M hybrid securities

      • SOP.FP (Sopra Steria Group) -- retires ~858K treasury shares; intends to launch a new up to €40M share buyback program in 2026

      • SLR.SM (Solaria Energia) -- placing up to 12.5M shares via accelerated book-build through Banco Santander, Barclays, BofA , Goldman, Société Générale

      • Amazon to offer OpenAI models; Commerce Dept drops privacy probe of Meta's WhatsApp in intraday themes (28-Apr)

  • Key rating changes

    • Upgrades

      • AKRBP.NO (Aker BP) -- to buy from hold at DNB Carnegie

      • EQNR.NO (Equinor) -- to hold from sell at DNB Carnegie

      • ITM.LN (ITM Power) -- to overweight from equal-weight at Morgan Stanley

      • VACN.SW (VAT Group) -- to buy from neutral at Goldman Sachs

      • VAR.NO (Vår Energi) -- to hold from sell at DNB Carnegie

      • YIT.FH (Yit) -- to accumulate from reduce at Inderes

    • Initiations

      • SFER.IM (Salvatore Ferragamo) -- underperform at Jefferies

    • Other Actions

      • WLN.FP (Worldline) -- resumed neutral at Oddo; prior rating was neutral

  • Data

    • Nikkei closed

    • Hang Seng +1.50% to 26063.71

    • Shanghai Composite +0.60% to 4103.13

    • S&P futures +16.0 vs prior close of 7171.0

    • €-$ (0.0008) or (0.07%) to 1.1704

    • $-¥ +0.07 or +0.04% to 159.69

    • €-¥ (0.15) or (0.08%) to 186.81

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.